A5083190834- Inflammatory Bowel Disease
- Microscopic Colitis
- Eosinophilic Esophagitis
- Colorectal Cancer Screening and Detection
- Pharmaceutical studies and practices
- Diagnosis and treatment of tuberculosis
- Celiac Disease Research and Management
- Gastrointestinal motility and disorders
- Diverticular Disease and Complications
- Innovations in Medical Education
- Gastric Cancer Management and Outcomes
- Pregnancy and Medication Impact
- Pharmaceutical Practices and Patient Outcomes
- Immunodeficiency and Autoimmune Disorders
- Autoimmune and Inflammatory Disorders
- Inflammatory mediators and NSAID effects
- Anatomy and Medical Technology
- Venous Thromboembolism Diagnosis and Management
- Adolescent and Pediatric Healthcare
- Healthcare Operations and Scheduling Optimization
- Biosimilars and Bioanalytical Methods
- Medical Education and Admissions
- Patient-Provider Communication in Healthcare
- Autoimmune and Inflammatory Disorders Research
- Esophageal Cancer Research and Treatment
University of Virginia
2012-2022
University of Virginia Health System
2013-2019
Johns Hopkins University
2007-2014
Johns Hopkins Medicine
2007-2008
University of Toronto
2007
Mount Sinai Hospital
2007
Recent epidemiological studies suggest that the prevalences of Crohn's disease (CD) and ulcerative colitis (UC) are increasing in United States. We sought to determine whether nationwide rates inflammatory bowel (IBD) hospitalizations have increased response temporal trends prevalence.We identified all admissions with a primary diagnosis CD or UC, 1 their complications Nationwide Inpatient Sample between 1998 2004. National estimates hospitalization surgery were determined using U.S. Census...
Nonadherence to medications is common with patients inflammatory bowel disease (IBD). The aim of this study was assess adherence biologic prescribed for IBD and identify risk factors nonadherence.This a single center retrospective cohort investigating patient therapies over 2-year period from September 2014 2016. Specialty pharmacy infusion records were obtained modified medication possession ratio calculated. Patient characteristics associated nonadherence in univariate model placed into...
BACKGROUND Practice guidelines advocate performing cholecystectomy for acute gallstone pancreatitis during the same hospitalization stay. Our objectives were to determine nationwide rates of adherence these in United States and whether this varied with race ethnicity. METHODS We queried Nationwide Inpatient Sample (NIS) identify admissions between 1998 2003. calculated overall race-specific proportions patients who underwent or endoscopic retrograde cholangiopancreatography (ERCP) prior...
The rate of narcotic misuse in the inflammatory bowel disease population is not well studied. primary aim this study was to determine Crohn's (CD) whether a concurrent functional gastrointestinal disorder (FGID) associated with increased rates chronic use. Second, we aimed identify potential risk factors for misuse.A retrospective chart review patients CD followed at University Virginia's Gastroenterology Clinic from 2006 2011 performed. prescription monitoring program accessed confirm...
Patients with inflammatory bowel disease (IBD) are at increased risk of thromboembolic events. The aim this study was to assess whether treatment anti-tumor necrosis factor-α (TNF-α) therapy associated a decreased thromboembolism.We identified IBD patients hospitalized between July 2002 and 2011 our institution. Demographic data, medications, indication for hospitalization, type event were obtained by chart review. Wald tests used calculate an association clinical characteristics...
Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics polypharmacy in an ulcerative colitis (UC) population assess impact of on disease Methods A retrospective chart review patients UC who visited tertiary medical center outpatient clinic between 2006 2011 was performed. defined as major ( ⥠5 non-UC medications) or minor (2-4...
As medical schools implement integrated curricula, anatomy education especially has experienced increased pressure to make foundational content clinically relevant. We designed a novel type of integrative laboratory experience where students could use concepts in concert with modern imaging/diagnostic techniques enhance important clinical concepts.We selected process called Lesson Study develop the multidisciplinary Clinical Anatomy and Imaging Laboratory (CAIL) cardiovascular...
Clinical Scenario: A 60 year old African American gentleman with a history of high blood pressure on olmesartan for the past 7 years presents 6 month diarrhea consisting 3-4 loose, non-bloody bowel movements day, associated ten pound weight loss over that time period. He has no known personal or family inflammatory disease, Celiac colon cancer. Physical exam was normal. On laboratory evaluation, exception an albumin 3.3 and Hgb 12.6 (MCV 89), CBC, CMP, ESR, CRP, TSH were within normal...
BACKGROUNDPatients with ulcerative colitis (UC) may be exposed to opioids over their disease duration.The use of such medications carries significant risk, including intestinal dysmotility and potential for addiction.However, the rates narcotic misuse in patients UC have not been studied extensively.Functional gastrointestinal disorders (FGID) are prevalent UC, shown increase risk Crohn's disease.We hypothesized that a concurrent diagnosis FGID would increased both opioid our patient cohort....
Objectives The purpose of this review was to compare the efficacy and safety biologics, immunomodulators, corticosteroids, aminosalicylates in treatment Crohn's disease. Data sources We searched MEDLINE® (1966 through June 2011), Embase® (1974 Cochrane Central Register Controlled Trials (Issue 2, 2011). Review methods Two reviewers independently reviewed titles, abstracts, articles, included English-language articles that reported on induction or maintenance remission placebo-controlled...
With rates of prescription drug misuse increasing, many states have implemented monitoring programs (PMPs). The rate narcotic in the IBD population is not well studied. primary aim this study was to determine patients with Crohn’s disease whether a concurrent functional GI disorder (FGID) associated increased chronic use. Second, we aimed identify potential risk factors for patient population. A retrospective chart review all followed at University Virginia’s Digestive Health Center...